Learn more about our Payment & Health Care Delivery Policy work.
AdvaMed®, the Medtech Association, today said two new final payment rules from the Centers for Medicare and Medicaid Services (CMS) for 2025 contain several important provisions that will improve access…
AdvaMed®, the Medtech Association, called on Medicare in a letter sent Friday to cover supplemental imaging for women with heterogeneously and extremely dense breast tissue, noting the life-saving value of…
WASHINGTON – AdvaMed®, the Medtech Association, today praised The Centers for Medicare and Medicaid Services (CMS) Hospital Outpatient Prospective Payment System (HOPPS) and Ambulatory Surgical Center Payment System rule for…
AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the final Transitional Coverage for Emerging Technologies (TCET) notice from the Centers for Medicare and…
This week, AdvaMed®, the Medtech Association, hosted an Artificial Intelligence (AI) Demonstration Day event on Capitol Hill showcasing AI-enabled medical devices and technologies from leading health care companies. The event…
Today, the Centers for Medicare and Medicaid Services (CMS) issued the Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System proposed rule for CY25, which includes significant wins…
The House Ways and Means Committee voted to pass the bipartisan H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act, during a markup meeting.
This week, AdvaMed®, the Medtech Association, applauded a bipartisan group of Senators for urging the Centers for Medicare & Medicaid Services (CMS) to develop a formalized payment pathway for algorithm-based health…
AdvaMed®, the Medtech Association, unveiled a timer on the organization’s website to track the number of days since the Centers for Medicare and Medicaid Services (CMS) ended the coverage pathway…
Gain insights from leaders from CMS and industry experts as they delve into medtech payment policies, private payer challenges and more.